| 5R01AG052510-05 |
2022 |
$2959649 |
Escitalopram for Agitation in Alzheimer Disease |
| 3R01AG052510-04S1 |
2021 |
$332357 |
Escitalopram for Agitation in Alzheimer Disease |
| 3R01AG052510-03S3 |
2021 |
$332237 |
The Coronavirus Pandemic, Caregiver Distress, And Neuropsychiatric Symptoms In Individuals With Alzheimer's Disease |
| 5R01AG052510-04 |
2021 |
$3521438 |
Escitalopram for Agitation in Alzheimer Disease |
| 3R01AG052510-03S2 |
2019 |
$379256 |
Escitalopram for Agitation in Alzheimer Disease - Actigraph Supplement |
| 5R01AG052510-03 |
2018 |
$3011794 |
Escitalopram for Agitation in Alzheimer Disease |
| 3R01AG052510-03S1 |
2018 |
$120368 |
Escitalopram for Agitation in Alzheimer Disease - Blood Biomarker Banking Supplement |
| 5R01AG052510-02 |
2017 |
$3000455 |
Escitalopram for Agitation in Alzheimer Disease |
| 1R01AG052510-01 |
2016 |
$3183018 |
ESCITALOPRAM FOR AGITATION IN ALZHEIMER DISEASE |
